Literature DB >> 22478735

Digestive diseases: epidemiology, economics, and the pipeline.

Lola Butcher.   

Abstract

Prevalence of disease, economics of care, the drug development pipeline, and implications for payers.

Year:  2008        PMID： 22478735      PMCID： PMC2702182     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  8 in total

1.  A practical perspective on ulcerative colitis: patients' needs from aminosalicylate therapies.

Authors:  Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2006-12       Impact factor: 5.325

2.  National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data.

Authors:  Lola J Kozak; Maria F Owings; Margaret J Hall
Journal:  Vital Health Stat 13       Date:  2005-03

Review 3.  Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Nicole T Moulding; Ian G Wilson; Jane M Andrews; Gerald J Holtmann
Journal:  Inflamm Bowel Dis       Date:  2007-02       Impact factor: 5.325

4.  Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

Authors:  Conor G Loftus; Edward V Loftus; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; L Joseph Melton; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

5.  Prevalence of selected chronic conditions: United States, 1990-1992.

Authors:  J G Collins
Journal:  Vital Health Stat 10       Date:  1997-01

6.  Annual cost of care for Crohn's disease: a payor perspective.

Authors:  B G Feagan; M G Vreeland; L R Larson; M V Bala
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

7.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999--2000.

Authors:  Catharine W Burt; Susan M Schappert
Journal:  Vital Health Stat 13       Date:  2004-09

8.  Infliximab decreases resource use among patients with Crohn's disease.

Authors:  Joel H Rubenstein; Rachel Y Chong; Russell D Cohen
Journal:  J Clin Gastroenterol       Date:  2002-08       Impact factor: 3.062
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.